Do we need randomised trials to evaluate diagnostic procedures?
- 29 November 2003
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 31 (1) , 129-131
- https://doi.org/10.1007/s00259-003-1384-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003
- Are Health Technology Assessments a reliable tool in the analysis of the clinical value of PET in oncology? Who audits the auditors?European Journal of Nuclear Medicine and Molecular Imaging, 2003
- The value of [18F]fluoro-2-deoxy-?-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatmentLung Cancer, 2003
- Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitalsThorax, 2002
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- DiscussionJournal of Clinical Epidemiology, 1999
- Evidence-based diagnostic radiologyThe Lancet, 1997
- Investigation for mediastinal disease in patients with apparently operable lung cancerThe Annals of Thoracic Surgery, 1995
- Evaluating and comparing imaging techniques: a review and classification of study designsThe British Journal of Radiology, 1987
- Randomized Clinical TrialsNew England Journal of Medicine, 1976